Bang & Olufsen A/S
21.9.2026 08:00:00 CEST | Globenewswire | Press release
Major Shareholder Announcement
Major Shareholder Announcement
Major shareholder announcement
Bang & Olufsen A/S has, pursuant to the Danish Capital Markets Act, received a major shareholder notification from UBS Group AG.
- As per 14 September 2026, UBS Group AG’s holding of shares and voting rights pursuant to section 38 of the Danish Capital Markets Act, as well as other financial instruments pursuant to section 39(2), was above 5 percent of the total share capital and voting rights in Bang & Olufsen A/S.
- As per 15 September 2026, UBS Group AG’s holding of shares and voting rights pursuant to section 38 of the Danish Capital Markets Act, as well as other financial instruments pursuant to section 39(2), was below 5 percent of the total share capital and voting rights in Bang & Olufsen A/S.
- As per 16 September 2026, UBS Group AG’s holding of shares and voting rights pursuant to section 38 of the Danish Capital Markets Act, as well as other financial instruments pursuant to section 39(2), was above 5 percent of the total share capital and voting rights in Bang & Olufsen A/S.
As of 16 September 2026, UBS Group AG held a total of 7,682,951 shares and voting rights in Bang & Olufsen A/S, corresponding to 5.21 percent of the total share capital and voting rights.
For further information, please contact:
Cristina Rønde Hefting
Sr. Director, Head of Strategy & Investor Relations
Phone: +45 4153 7303
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chemometec A/S5.10.2026 21:52:21 CEST | Press release
Major shareholder announcement - BlackRock, Inc.
Chemometec A/S5.10.2026 21:52:21 CEST | Pressemeddelelse
Storaktionærmeddelelse - BlackRock, Inc.
Tryg A/S5.10.2026 21:21:26 CEST | Pressemeddelelse
Storaktionærmeddelelse
Tryg A/S5.10.2026 21:21:26 CEST | Press release
Major Shareholder Announcement
Genmab A/S5.10.2026 20:49:00 CEST | Press release
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom